Home » Newsletters » BioWorld Asia

BioWorld Asia

June 20, 2001

View Archived Issues

MelTec, Evotec Form Venture For Drug Discovery, Services

Heat-Shock Proteins Suggest New Mode Of Attack On TB

Cyclacel Raises $47.7M For Cell-Cycle Cancer Programs

Meristem Enters Cystic Fibrosis Licensing Agreement With Solvay

Ethypharm Sets Target Of $137M For IPO in France

Parliament Genetics Debate Takes Pro-Industry Direction

Galapagos, Bayer Enter Deal To Discover Protein Functions

Association Seeks More Options For Biotechnology Product Filings

Other News To Note

DeCODE Enters Monoclonal Antibody Deal With Genmab

Zentaris Cites Market Conditions In Postponing IPO In Germany

Oxford Glyco, Marconi Create Venture For Protein Databases

Amaxas Second Round Nets EUR13M For Transfection Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...